Skip to main content
Home
Dana-Farber logo Harvard Medical School logo

Search form

  • Home
  • Members
  • Research
  • PRoXe
  • News
  • Contact
  • Publications

Site map

Main menu

  • Home
  • Members
    • David Weinstock
    • Administration
    • Researchers
    • Alumni
  • Research
    • Advancing the treatment of T-cell lymphomas
    • Targeting B-cell malignancies with poor prognosis
    • Identifying factors that affect chromosomal translocation formation
    • Defining therapeutic sensitivity of single cancer cells by measuring cell mass
    • Developing human xenograft models of leukemia and lymphoma
    • Novel Diagnostics for Lymphoma in Guatemala
  • PRoXe
  • News
    • Cancer research with a human touch
    • Novartis transfers hundreds of tumor models to DFCI bank Creates resource for researchers around the world
    • Dana-Farber’s bank of patient-derived tumor xenografts gets major boost from Novartis
    • Modeling Human Immunity and Disease
    • Over the river and do some good
    • SOLUTIONS with/in/sight: Bridging the Gaps Between Remission and Cure
    • Acute Myeloid Leukemia: Using Patient-Derived Xenografts to Grapple with Disease Complexity
  • Contact
  • Publications
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010

Weinstock Laboratory logo

Dana-Farber Cancer Institute logo

Harvard Medical School logo

  • Sitemap
  • Contact
  • Admin

Copyright 2016 | Privacy policy | Legal statements
Site developed by Health Communication Core